Literature DB >> 21601421

Right ventricular myocardial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction.

Daniel A Morris1, Mudather Gailani, Amalia Vaz Pérez, Florian Blaschke, Rainer Dietz, Wilhelm Haverkamp, Cemil Özcelik.   

Abstract

OBJECTIVE: We hypothesized that in patients with heart failure with normal left ventricular (LV) ejection fraction (HFNEF), the same fibrotic processes that affect the subendocardial layer of the LV could also alter the subendocardial fibers of the right ventricle (RV). Consequently, these alterations and to a lesser extent chronically elevated pulmonary arterial pressures would lead to both systolic and diastolic subendocardial dysfunction of the RV (i.e., impaired RV longitudinal systolic and diastolic function) in patients with HFNEF.
METHODS: Patients with HFNEF and a control group consisting of asymptomatic patients with LV diastolic dysfunction (asymptomatic LVDD) matched by age, gender, and LV ejection fraction were studied by two-dimensional speckle-tracking echocardiography.
RESULTS: A total of 565 patients were included (201 with HFNEF and 364 with asymptomatic LVDD). RV longitudinal diastolic (RV global longitudinal early-diastolic strain rate [RV-SRe]) and systolic (RV global longitudinal systolic strain [RV-Strain]) function were significantly more impaired in patients with HFNEF than in patients with asymptomatic LVDD (HFNEF: RV-Strain -14.41% ± 3.80% and RV-SRe 0.86 ± 0.33 s(-1); asymptomatic LVDD: RV-Strain -16.90% ± 4.28% and RV-SRe 1.02 ± 0.34 s(-1); all P < .0001). On multiple regression analysis, LV global longitudinal systolic strain was the most important independent predictor of RV longitudinal systolic and diastolic function, in contrast with pulmonary arterial systolic pressure, which was weakly related to these functions. Furthermore, in patients with HFNEF the subendocardial function of both the LV and RV were significantly impaired in similar proportions. In that regard, in patients with HFNEF the prevalences of RV longitudinal systolic and diastolic dysfunction were 75% and 48%, whereas the rates of LV longitudinal systolic and diastolic dysfunction were 80% and 60%, respectively. In addition, patients with both systolic and diastolic longitudinal dysfunction of the RV presented worse New York Heart Association functional class.
CONCLUSION: In patients with HFNEF, RV subendocardial systolic and diastolic dysfunction are common and possibly associated with the same fibrotic processes that affect the subendocardial layer of the LV and to a lesser extent with RV pressure overload. Furthermore, our findings suggest that RV longitudinal systolic and diastolic dysfunction could contribute to the symptomatology of patients with HFNEF.
Copyright © 2011 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21601421     DOI: 10.1016/j.echo.2011.04.005

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  19 in total

1.  Right ventricular function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Imad Hussain; Omar F AbouEzzeddine; Omar F Abou Ezzeddine; Hiroyuki Takahama; Susan H Kwon; Paul Forfia; Véronique L Roger; Margaret M Redfield
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

2.  It is time to look at heart failure with preserved ejection fraction from the right side.

Authors:  Neal A Chatterjee; Johannes Steiner; Gregory D Lewis
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

3.  Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status.

Authors:  Daniel A Morris; Daniela Blaschke; Sima Canaan-Kühl; Alice Krebs; Gesine Knobloch; Thula C Walter; Wilhelm Haverkamp
Journal:  Int J Cardiovasc Imaging       Date:  2014-10-15       Impact factor: 2.357

Review 4.  Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy.

Authors:  Chike C Nwabuo; Ramachandran S Vasan
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

5.  Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult Pompe disease.

Authors:  Daniel A Morris; Daniela Blaschke; Alice Krebs; Sima Canaan-Kühl; Ursula Plöckinger; Gesine Knobloch; Thula C Walter; York Kühnle; Leif-Hendrik Boldt; Elisabeth Kraigher-Krainer; Burkert Pieske; Wilhelm Haverkamp
Journal:  Int J Cardiovasc Imaging       Date:  2015-03-06       Impact factor: 2.357

6.  Associations of Macro- and Microvascular Endothelial Dysfunction With Subclinical Ventricular Dysfunction in End-Stage Renal Disease.

Authors:  Ruth F Dubin; Isabella Guajardo; Amrita Ayer; Claire Mills; Catherine Donovan; Lauren Beussink; Rebecca Scherzer; Peter Ganz; Sanjiv J Shah
Journal:  Hypertension       Date:  2016-08-22       Impact factor: 10.190

7.  Right atrial-right ventricular coupling in heart failure with preserved ejection fraction.

Authors:  Maximilian von Roeder; Johannes Tammo Kowallick; Karl-Philipp Rommel; Stephan Blazek; Christian Besler; Karl Fengler; Joachim Lotz; Gerd Hasenfuß; Christian Lücke; Matthias Gutberlet; Holger Thiele; Andreas Schuster; Philipp Lurz
Journal:  Clin Res Cardiol       Date:  2019-05-03       Impact factor: 5.460

8.  Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.

Authors:  Michael A Burke; Daniel H Katz; Lauren Beussink; Senthil Selvaraj; Deepak K Gupta; Justin Fox; Sudarsana Chakrabarti; Andrew J Sauer; Jonathan D Rich; Benjamin H Freed; Sanjiv J Shah
Journal:  Circ Heart Fail       Date:  2013-12-23       Impact factor: 8.790

Review 9.  Epidemiology of Right Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction.

Authors:  Rosita Zakeri; Selma F Mohammed
Journal:  Curr Heart Fail Rep       Date:  2015-10

Review 10.  Developing therapies for heart failure with preserved ejection fraction: current state and future directions.

Authors:  Javed Butler; Gregg C Fonarow; Michael R Zile; Carolyn S Lam; Lothar Roessig; Erik B Schelbert; Sanjiv J Shah; Ali Ahmed; Robert O Bonow; John G F Cleland; Robert J Cody; Ovidiu Chioncel; Sean P Collins; Preston Dunnmon; Gerasimos Filippatos; Martin P Lefkowitz; Catherine N Marti; John J McMurray; Frank Misselwitz; Savina Nodari; Christopher O'Connor; Marc A Pfeffer; Burkert Pieske; Bertram Pitt; Giuseppe Rosano; Hani N Sabbah; Michele Senni; Scott D Solomon; Norman Stockbridge; John R Teerlink; Vasiliki V Georgiopoulou; Mihai Gheorghiade
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.